220193-52-2

Basic information

• Product Name: (2S)-2-amino-N₁-[3-(1-naphthalenyl)propyl]butanediamide
• Synonyms: (2S)-2-amino-N₁-[3-(1-naphthalenyl)propyl]butanediamide
• CAS NO: 220193-52-2
• Molecular Weight: 424.543
• Mol File: 220193-52-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2S)-2-amino-N₁-[3-(1-naphthalenyl)propyl]butanediamide(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-2-amino-N₁-[3-(1-naphthalenyl)propyl]butanediamide(220193-52-2)
• EPA Substance Registry System: (2S)-2-amino-N₁-[3-(1-naphthalenyl)propyl]butanediamide(220193-52-2)

Safety Data

• Hazardous Substances Data: 220193-52-2(Hazardous Substances Data)

Upstream product

• 220193-51-1 {1-[2-carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-cyclohexyl}-carbamic acid tert-butyl ester 

Downstream Products

• 220193-85-1 2-tert-butoxycarbonylmethoxy-5-(2-(tert-butoxyoxalyl-amino)-2-{1-[2-carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-cyclohexylcarbamoyl}-ethyl)-benzoic acid 2-trimethylsilanyl-ethyl ester 
• 220193-74-8 5-((S)-2-Acetylamino-2-{1-[(S)-2-carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-cyclohexylcarbamoyl}-ethyl)-2-tert-butoxycarbonylmethoxy-benzoic acid 2-trimethylsilanyl-ethyl ester 
• 220193-81-7 N-{1-{1-[2-carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-cyclohexylcarbamoyl}-2-[4-(di-tert-butoxy-phosphorylmethyl)-phenyl]-ethyl}-oxalamic acid tert-butyl ester 
• 220193-82-8 N-{1-{1-[2-carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-cyclohexylcarbamoyl}-2-[4-(di-tert-butoxy-phosphorylmethyl)-phenyl]-ethyl}-oxalamic acid tert-butyl ester 
• 220193-73-7 [5-(2-acetylamino-2-{1-[2-carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-cyclohexylcarbamoyl}-ethyl)-2-tert-butoxycarbonylmethoxy-phenoxy]-acetic acid tert-butyl ester 
• 220193-87-3 N-[(S)-1-{1-[(S)-2-Carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-cyclohexylcarbamoyl}-2-(4-phosphonomethyl-phenyl)-ethyl]-oxalamic acid 
• 220193-87-3 N-[(R)-1-{1-[(S)-2-Carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-cyclohexylcarbamoyl}-2-(4-phosphonomethyl-phenyl)-ethyl]-oxalamic acid 
• 220193-71-5 [4-((S)-2-Acetylamino-2-{1-[(S)-2-carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-cyclohexylcarbamoyl}-ethyl)-benzyl]-phosphonic acid di-tert-butyl ester 
• 220193-70-4 {[4-((S)-2-Acetylamino-2-{1-[(S)-2-carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-cyclohexylcarbamoyl}-ethyl)-phenyl]-difluoro-methyl}-phosphonic acid diethyl ester 
• 220193-83-9 [4-((S)-2-Amino-2-{1-[(S)-2-carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-cyclohexylcarbamoyl}-ethyl)-benzyl]-phosphonic acid di-tert-butyl ester 
• 220193-67-9 2-({1-[2-acetylamino-3-(4-tert-butoxy-phenyl)-propionylamino]-cyclohexanecarbonyl}-amino)-N¹-(3-naphthalen-1-yl-propyl)-succinamide 

Relevant articles and documents

Potent inhibition of Grb2 SH2 domain binding by non-phosphate- containing ligands

Development of Grb2 Src homology 2 (SH2) domain binding inhibitors has important implications for treatment of a variety of diseases, including several cancers. In cellular studies, inhibitors of Grb2 SH2 domain binding have to date been large, highly cha